CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in ...

A recent clinical trial highlights how a high-fiber plant-based diet can improve health markers and potentially delay the ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

Conquer Cancer®, the ASCO Foundation, presented the 2025 Young Investigator Awards (YIAs) funded by Vaniam Group™ and Women ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

Doctors have said there is a risk that weight loss jabs such as Ozempic and Mounjaro could raise the risk of being diagnosed ...

A new study from researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine provides fresh ...